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Abstract
Background: Erythrocytes of diabetic cats have decreased superoxide dismutase
activity, possibly indicative of oxidative stress.
Hypothesis: Erythrocytes of diabetic cats undergo oxidative stress, which is caused
by hyperglycemia and hyperlipidemia, and improves with treatment.
Animals: Twenty-seven client-owned cats with diabetes mellitus, 11 matched healthy
cats, and 21 purpose-bred healthy cats.
Methods: Prospective study. Advanced oxidized protein products, carbonyls (protein
oxidation by-products), and thiols (antioxidants) were quantified in erythrocyte mem-
brane, thiobarbituric acid reactive substances (TBAR, lipid peroxidation by-products),
and thiols in erythrocyte cytoplasm of all cats. Comparison were performed between
diabetic and matched healthy cats, between diabetic cats achieving remission or not,
and among purpose-bred cats after 10 days of hyperglycemia (n = 5) or hyperlipid-
emia (n = 6) versus controls treated with saline (n = 5) or untreated (n = 5).
Results: Compared with controls, erythrocytes of diabetic cats initially had higher
median membrane carbonyls (4.6 nmol/mg total protein [range: 0.1-37.7] versus 0.7
[0.1-4.7], P < .001) and lower cytoplasmic TBAR (1.9 nmol/mg [0.5-2.4] versus 2.4
[1.4-3.5] P < .001), and thiols (419 nmol/mg [165-621] versus 633 [353-824],
P < 0.001). After 12-16 weeks of treatment in diabetic cats, carbonyls decreased by
13% (P < .001), but remained higher (P < .001) and TBAR and thiols lower (P = .02,
P < .001) than those in controls. No differences were observed between diabetic cats
achieving remission or not, and among purpose-bred cats.
Conclusions and Clinical Importance: Diabetes mellitus is associated with increased
protein oxidation and reduced antioxidant defenses, which persist during treatment
Abbreviations: AOPP, advanced oxidized protein products; DM, diabetes mellitus; TBAR, thiobarbituric acid reactive substances.
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and remission, although mild improvement in protein oxidation occurs. Short-term
hyperglycemia or hyperlipidemia does not cause oxidative stress. The reason for
decreased TBAR remains unknown.
K E YWORD S
cats, diabetes mellitus, feline, oxidation, red blood cells
1 | INTRODUCTION
Oxidative stress is defined as an excess of reactive oxygen species rel-
ative to antioxidants that may induce tissue injury, in particular by
causing structural and functional changes in proteins and lipids.1,2 Oxi-
dative stress can be assessed by measurement of by-products of pro-
tein, lipid, and DNA oxidation and quantification of antioxidants.
By-products of protein oxidation include carbonyls, which comprise
aldehydes after interacting with reactive oxygen species,2 and
advanced oxidized protein products (AOPP), which form disulfide
bridges and dityrosine cross-links after contacting neutrophil
myeloperoxidase.3 Thiobarbituric acid reactive substances (TBAR) are
ketones and aldehydes, including malondialdehyde, derived from per-
oxidation of polyunsaturated fatty acids.4 Antioxidants include the
group of thiols that serve to counteract the effect of free radicals5;
glutathione is the most important thiol. Enzymes, such as glutathione
peroxidase and superoxide dismutase, and certain vitamins including
C and E also serve as antioxidants.5
Oxidative stress is a well-recognized feature of type 2 diabetes
mellitus (DM) in humans.6 Diabetic humans have an increase in the
concentration of carbonyls, AOPP, and TBAR, although the concentra-
tion of thiols and vitamins, and the activity of antioxidant enzymes are
decreased.6-11 Furthermore, oxidative stress negatively correlates
with glycemic control, and lowering blood glucose concentration ame-
liorates oxidative stress.12,13 Hyperglycemia and hyperlipidemia,
which characterize the diabetic milieu, are thought to be the major
contributors of oxidative stress in humans.14,15
Oxidative status is generally assessed in erythrocytes, tissues, and
plasma; however, because erythrocytes are exposed to biochemical
damage and can be easily collected, they are frequently analyzed.16,17
Oxidative stress in erythrocytes has also been the focus of research in
cats with DM. The activity of superoxide dismutase in erythrocytes is
lower in diabetic cats than in controls and does not increase during
treatment. In addition, in diabetic cats the whole blood activity of glu-
tathione peroxidase is not decreased and the concentration of
malondialdehyde is not increased at the beginning or at the end of the
investigation.18 Concentrations of TBAR and glutathione in erythro-
cytes do not differ between diabetic cats and healthy controls,19
although erythrocytes of diabetic cats consistently have Heinz bodies,
possibly indicating oxidative damage to hemoglobin.20 Thus, evidence
of oxidative stress in cats with DM is currently very limited. The role
of hyperglycemia and hyperlipidemia in the pathogenesis of oxidative
stress has not yet been studied in cats.
Because remission of DM in cats is associated with tight glycemic
control and normal serum cholesterol concentration,21,22 it is possible
that oxidative stress in cats achieving remission is lower compared
with diabetic cats that are not in remission. Thus, the aims of the
study were to determine if erythrocytes of diabetic cats undergo oxi-
dative stress compared with a well-matched control group and if
hyperglycemia and hyperlipidemia, which are hallmarks of DM, are
responsible for oxidative stress in the erythrocytes of purpose-bred
healthy cats. In addition, based on whether oxidative stress could be
shown in erythrocytes of cats with DM, it was determined if treat-
ment improves oxidative stress and if the degree of oxidative stress
differs between diabetic cats in remission and those that do not
achieve remission.
2 | MATERIALS AND METHODS
2.1 | Cat groups
Three groups of cats were included in the study: cats with DM;
healthy control cats matched by age, body weight, body condition
score, breed, and sex to the diabetic group; and purpose-bred healthy
cats from a former investigation.23
2.2 | Cats with DM and healthy control cats
Cats with newly diagnosed DM were prospectively enrolled in the
study, as previously described.24 Cats were excluded if they had
received insulin treatment for longer than 1 week before admission,
and if glucocorticoids or progestagens had been administered during
the previous 4 months. On admission, all cats underwent thorough
evaluation including a physical examination, complete blood cell
count, serum biochemistry, fructosamine, total T4 concentration, and
serum feline pancreas-specific lipase activity, urinalysis with bacterial
culture and urinary protein-to-creatinine ratio, blood pressure mea-
surement, abdominal and thoracic radiography, and abdominal ultraso-
nography. Cats with a concurrent disease, such as renal failure,
gastrointestinal disorders, heart disease, other endocrinopathies, neo-
plasia, or clinically relevant pancreatitis, were excluded from the
study. Diabetic cats with ketoacidosis were included if acidemia
resolved and the general health status improved within 48 hours of
insulin treatment.
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During the follow-up period, diabetic cats were treated with
glargine insulin (Lantus, Sanofi Aventis, Meyrin, Switzerland) and fed a
high-protein, low-carbohydrate diet (DM, Nestlé Purina, Lausanne,
Switzerland). Re-evaluations were scheduled at 1, 2-3, 6-8, 12-16,
and 24 weeks. Insulin dosage adjustments were based on clinical
signs, results of physical examination, fructosamine concentration,
and blood glucose curves. Remission of DM was defined as the
absence of associated clinical signs (eg, polyuria and polydipsia, poly-
phagia) accompanied by normal blood glucose (72-162 mg/dL) and
fructosamine concentration (<340 μmol/L) for at least 4 weeks after
discontinuation of insulin treatment.22 The insulin dosage was gradu-
ally decreased in steps of 0.5 IU twice daily, each week, whenever
possible. The last dosage before discontinuation of insulin treatment
was 0.5 IU once daily, for at least 1 week. Cats that required insulin
throughout the study were defined as not being in diabetic remission.
Erythrocytes from blood samples collected at the time of diagnosis
and 6-8 and 12-16 weeks later were used to investigate oxidative
stress.
Healthy control cats were recruited from owners that had been
offered health screening for their pets. The cats were included if the
results of physical examination, complete blood cell count, and serum
biochemistry, fructosamine, and total T4 concentrations were within
their respective reference intervals. Erythrocytes from the samples col-
lected for complete blood cell counts were used for analysis.
2.3 | Purpose-bred healthy cats, hyperglycemic,
and hyperlipidemic clamps
Twenty-one healthy cats, based on normal physical examination, com-
plete blood cell count, and serum biochemistry were used (Charles
River, L'Arbresle, France). Cats were randomly divided into 4 groups;
groups I, II, and III received an intravenous infusion via an indwelling
jugular vein catheter over a 10-day period, as previously described.23
In brief, group I (5 cats) received 50% glucose (Glukose 50%,
Kantonsapotheke, Zurich, Switzerland) added to saline; blood glucose
was evaluated 6-12 times daily, and the infusion rate was adjusted to
clamp glucose concentration at 25-30 mmol/L. Group II (6 cats)
received lipids (Lipovenoes 10%, Fresenius-Kabi, Bad Homburg, Ger-
many); blood triglycerides were measured 2-3 times daily to clamp the
concentration at 3-7 mmol/L. The glucose and triglyceride concentra-
tions used reflected those found in untreated diabetic cats at the
authors' institution. Group III (5 cats) served as controls and received
intravenous saline solution. During the 10-day infusion, cats were
housed in individual cages. The remaining 5 control cats (group IV)
were housed as a group, did not receive treatment, and served to
assess experimental stress on well-being. All cats had free access to
water and were fed a commercial dry food for adult cats twice daily.
The amount of food was quantified to meet the daily energy require-
ments of each cat. Erythrocytes from blood samples collected at the
end of the experiment (day 10) in all cats were used to investigate oxi-
dative stress.
2.4 | Oxidative status of erythrocytes
2.4.1 | Preparation of erythrocytes
Blood samples (1.5 mL) were collected from a jugular vein of all cats
into tubes containing EDTA and were centrifuged at 3000g for
10 minutes. Each sample was processed within 1 hour. The erythro-
cyte fraction was kept at −80C until analysis. Erythrocyte membrane
fractions were isolated by osmotic lysis of the washed erythrocytes
using 500 μL of lysis solution (5 mM sodium phosphate buffer at
pH 8.0 and 1 mM EDTA) with protease inhibitor cocktail (Sigma-
Aldrich, St Louis, Missouri) followed by high-speed centrifugation
(Optima L-90K, Beckman Coulter, Milano, Italy) at 25 000g for
20 minutes.25 The cytoplasm of erythrocytes (ie, supernatant) was
used to quantify TBAR and thiols, and the membranes to quantify car-
bonyls, AOPP, and thiols. Carbonyls and AOPP were not measured in
cytoplasm because of the presence of hemoglobin, which interferes
with the assays, and TBAR was not measured in membranes because
of limited sample availability.
The membranes were washed 3 times using 4 mL of 5 mM
sodium phosphate buffer (pH 8.0) and 1 mM EDTA and once using
1 mL of Tris 10 mM (pH 8.8) plus 0.1% Triton X-100 (Sigma-Aldrich),
and the hemoglobin was removed with the supernatant after each
wash. Membranes were resuspended in 200 μL of Tris 10 mM
(pH 8.8) with protease inhibitor cocktail, and were stored at −80C.
The total proteins were quantified by the bicinchoninic acid method
(BCA Protein Assay Kit, EuroClone, Milano, Italy).
2.4.2 | Variables of oxidation
Carbonyls were determined using dinitrophenylhydrazine (Sigma-
Aldrich).26 Briefly, 50 μL of erythrocyte membranes was added to
10 mM dinitrophenylhydrazine in 2.5 M HCl and allowed to stand
for 1 hour, followed by deproteinization with 20% TCA. The pro-
teins were washed 3 times in ethanol/ethyl acetate (1:1) and solu-
bilized in potassium phosphate 20 mM (pH 2.3). The concentration
of carbonyls was measured by spectrophotometry at an optic den-
sity of 370 nm with ε370 = 22 mM
−1 cm−1 and expressed as nmol/
mg total protein.
Determination of AOPP was based on spectrophotometric detec-
tion (Packard Instrument, Meriden, Connecticut).3 A total of 200 μL of
erythrocyte membranes diluted 1:6 with PBS (pH 7.4) and 200 μL of
chloramine-T (0-100 μmoL/L) for calibration was placed in the test
well. Ten microliters of 1.16 M KI and 20 μL of acetic acid was added,
and absorbance at 340 nm was measured immediately. The concen-
tration of AOPP was expressed in nmol/mL of chloramine-T equiva-
lents per milligram of proteins (nmol/mg).
Quantification of malondialdehyde content of erythrocyte
cytoplasm was done by the spectrophotometric TBAR determina-
tion.27 Five microliters of cytosol was added to 25 μL of 50 mM
monobasic sodium phosphate buffer, 25 μL of sodium dodecyl
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sulfate 8.1%, 187 μL of trichloroacetic acid (20%, pH 3.5), 187 μL of
thiobarbituric acid, and 100 μL of Milli-Q grade ultrapure water
(Merck Millipore, Milano, Italy), and the solution was incubated in
boiling water for 10 minutes. The solution was placed in a container
of ice for a few minutes to cool, and 125 μL of Milli-Q grade ultra-
pure water and 625 μL of n-butanol pyridine were added. The solu-
tion was then centrifuged at 7000g for 5 minutes. Duplicates of
150 μL of the supernatant of each reaction were placed into a
96-well microplate, and absorbance was read at 530 nm.
Tetramethoxypropane (TMOP, Sigma-Aldrich) was used as a stan-
dard (0.3-5 μM) to estimate TBAR formation as nmol of
malondialdehyde equivalents per milligram of total proteins.
2.4.3 | Variables of antioxidant defense
The concentration of thiols was determined based on
5-thio-2-nitrobenzoic acid formed from their reaction with Ellman's
reagent (5,50-dithiobisnitrobenzoic acid).28 Sulfhydryl groups were
quantified in erythrocyte cytoplasm (diluted 1:250) and membranes
(diluted 1:2) by comparing the results to a standard curve based on
known concentrations of cysteine (0.25-1.5 mM). The concentration
of thiols was measured by spectrophotometry at an optic density of
412 nm and expressed as nmol/mg total protein.
2.5 | Statistical analysis
The analyses were done with commercial software (SPSS version
24.0, IBM, Armonk, New York). Data were tested for normality
using the Shapiro-Wilk test. Variables used to assess oxidative
status were compared between diabetic cats (at the time of diag-
nosis) and healthy control cats using the t test or the Mann-
Whitney U test, depending on normality. Within diabetic cats,
comparison between those with and without remission was done
using the mixed-design analysis of variance model; the model
included the cat as the casual effect and the fixed effects of the
diagnostic category (remission versus no remission), the sampling
time point, and their combination. In addition, depending on nor-
mality, Pearson or Spearman coefficients were calculated in dia-
betic cats to identify correlations between variables used to
assess oxidative status and clinical and laboratory findings at the
time of diagnosis including body weight, body condition score
based on a 9-point scale (https://www.wsava.org/), and serum
concentrations of fructosamine, albumin, total protein, triglycer-
ides, and cholesterol. Differences in variables of oxidative stress
at the time of diagnosis versus 12-16 weeks later in cats with
remission and those without were analyzed using a paired t test
or Wilcoxon signed rank test, depending on normality. Compari-
son among the 4 groups of purpose-bred cats was achieved using
Kruskal-Wallis analysis of variance. Differences were considered
significant at P < .05.
3 | RESULTS
3.1 | Diabetic cats, diabetic remission, and healthy
control cats
Twenty-seven cats with newly diagnosed DM fulfilled the inclusion
criteria and were enrolled in the study. Median age was 10.0 years
(range: 7.0-15.0 years), median body weight was 5.1 kg (range:
2.5-9.6 kg), and median body condition score was 5 (range: 2-9).
Twenty-two were domestic shorthair or longhair cats and 5
were purebred cats (Abyssinian, Burmese, Ragdoll, Siamese, and
F IGURE 1 Before-and-after plot of membrane carbonyls in
erythrocytes of cats with diabetes mellitus (DM) at the time of
diagnosis and 12-16 weeks later, and dot plot of healthy control cats.
Diabetic cats had significantly higher concentrations than controls at
both time points. Compared with results at the time of diagnosis,
there was a significant decrease in the concentrations of diabetic cats
at the 12-16-week time point
F IGURE 2 Before-and-after plot of cytoplasmic thiobarbituric
acid reactive substances (TBAR) in erythrocytes of cats with diabetes
mellitus (DM) at the time of diagnosis and 12-16 weeks later, and dot
plot of healthy control cats. Diabetic cats had significantly lower
concentrations than controls at both time points. The concentrations
at the time of diagnosis and 12-16 weeks later did not differ in
diabetic cats
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Norwegian forest cat). Fifteen cats were neutered males and 12 were
spayed females. At the time of enrolment in the study, 2 of the cats
had ketoacidosis with acidemia that resolved within 1 day of fluid
and insulin treatment. None of the cats had clinical signs compatible
with pancreatic or gastrointestinal disease. The serum concentra-
tions of fructosamine, albumin, total protein, triglycerides, and cho-
lesterol are shown in the Supplemental Table S1. The median dose
of glargine insulin initially administered to cats was 1.0 IU (range:
0.5-1.5 IU), twice daily. Diabetic remission occurred in 15 (55.6%) of
the 27 cats during the follow-up period. In 7 of these, remission had
occurred by week 8 after the start of treatment, and in the remaining
8, it occurred 8-16 weeks after the start of treatment. After achiev-
ing remission, none of the cats relapsed during the 24-week study
period.
Eleven healthy cats with a median age of 7.0 years (range:
4.0-14.0 years), median body weight of 4.8 kg (range: 4.5-6.5 kg), and
a median body condition score of 5 (range: 5-7) were used as controls.
Ten were domestic shorthair cats and 1 was a Norwegian forest cat.
Six cats were neutered males and 5 were spayed females. Age, body
weight, body condition score, breed, and sex did not differ between
control and diabetic cats.
Overall, samples were collected during a 1.5-year period and oxi-
dative status was assessed after approximately 1 year.
3.1.1 | Variables of oxidation
At the time of diagnosis, erythrocytes of cats with DM had signifi-
cantly higher median concentrations of membrane carbonyls than
those of healthy control cats (4.6 nmol/mg [range: 0.1-37.7] versus
0.7 nmol/mg [range: 0.1-4.7]; P < .001; Figure 1). The variability in
diabetic cats was high. Of the 6 cats with values close to 0, all were
neutered males, 5 had a body weight >5 kg, 4 had a body condition
score ≥6, 5 had a serum fructosamine concentration >600 μmol/L,
and 3 achieved diabetic remission. In addition, erythrocytes of cats
with DM had lower cytoplasmic TBAR concentrations (1.9 nmol/mg
[range: 0.5-2.4]) than controls (2.4 nmol/mg [range: 1.4-3.5];
P < 0.001; Figure 2). The concentration of AOPP in erythrocyte mem-
branes did not differ between diabetic and healthy control cats.
Compared with initial values, erythrocytes of cats with DM had a
13% decrease in the median concentration of membrane carbonyls
(4.0 nmol/mg [range: 0.5-18.2]; P = .004) 12-16 weeks after diagnosis
and initiation of treatment, although the concentration was still signif-
icantly higher than that of healthy control cats (P < .001; Figure 1).
The median concentration of cytoplasmic TBAR in diabetic cats at
12-16 weeks [1.7 nmol/mg [range: 0.4-2.6]) did not differ from the
value determined at the time of diagnosis and remained significantly
lower than the median concentration in healthy controls (P < .001;
Figure 2). Membrane AOPP of diabetic cats at 12-16 weeks did not
differ from concentrations obtained at the time of diagnosis or from
values in healthy control cats (Figure 3).
Six to 8 weeks after the time of diagnosis, the concentration of
membrane AOPP was lower in diabetic cats in remission (31 nmol/mg
[range: 6-79]) than in diabetic cats that had not achieved remission
(51 nmol/mg[(range: 18-116]; P = .040); the concentration was similar
for carbonyls and TBAR. The results of variables reflecting oxidation
determined at the time of diagnosis and 12-16 weeks later did not dif-
fer between diabetic cats in remission and those that had not
achieved remission. Of note, in cats that achieved remission and in
those that did not achieve remission, there was a significant decrease
F IGURE 3 Before-and-after plot of membrane advanced oxidized
protein products (AOPP) in erythrocytes of cats with diabetes mellitus
(DM) at the time of diagnosis and 12-16 weeks later, and dot plot of
healthy control cats. Concentrations did not differ between diabetic
and healthy control cats at both time points. The concentrations at
the time of diagnosis and 12-16 weeks later did not differ in
diabetic cats
TABLE 1 Oxidative status of erythrocytes at the time of diagnosis and 12-16 weeks later in diabetic cats that did or did not achieve
remission
Variable
Remission (n = 15) No remission (n = 12)
Time of diagnosis 12-16 weeks
P-value
Time of diagnosis 12-16 weeks
P-valueMedian (range) Median (range) Median (range) Median (range)
Membrane carbonyls (nmol/mg) 11.9 (2.2-37.7) 5.6 (3.4-18.2) .04 4.6 (1.5-20.1) 2.8 (1.2-13.2) .04
Membrane AOPP (nmol/mg) 34 (6-82) 41 (17-90) .49 56 (14-102) 46 (33-104) .86
Cytoplasmic TBAR (nmol/mg) 2.0 (0.8-2.3) 1.9 (0.4-2.6) .25 1.9 (1.3-2.4) 1.6 (0.4-2.2) .65
Membrane thiols (nmol/mg) 132 (42-399) 134 (47-196) .57 132 (71-270) 102 (51-249) .25
Cytoplasmic thiols (nmol/mg) 447 (239-591) 480 (157-631) .83 479 (165-620) 443 (308-642) .83
Abbreviations: AOPP, advanced oxidized protein products; TBAR, thiobarbituric acid reactive substances.
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in the concentrations of membrane carbonyls but similar concentra-
tions of AOPP as well as cytoplasmic TBAR 12-16 weeks after diagno-
sis compared with initial values (Table 1).
3.1.2 | Variables of antioxidant defense
At the time of diagnosis, erythrocytes of cats with DM had a lower
median concentration of cytoplasmic thiols than those of healthy con-
trol cats (419 nmol/mg [range: 165-621] versus 633 nmol/mg [range:
353-824]; P < .001; Figure 4), whereas membrane thiols did not differ
between the 2 groups. After 12-16 weeks, the median concentration
of cytoplasmic thiols of erythrocytes in diabetic cats (471 nmol/mg
[range: 158-642]) did not differ from the initial median value and
remained significantly lower than the concentration in controls
(P = .02; Figure 4). At 12-16 weeks, the concentration of membrane
thiols of diabetic cats did not differ from initial values and those in
healthy control cats.
The concentration of cytoplasmic and membrane thiols did not
differ between diabetic cats in remission and diabetic cats not in
remission at any of the measurement points. When all cats with DM
were considered, the concentrations of cytoplasmic and membrane
thiols of cats in remission and of those not in remission did not differ
between the time of diagnosis and 12-16 weeks later (Table 1).
3.1.3 | Correlations between oxidative status and
clinical and laboratory findings
In diabetic cats, there was no correlation between any of the variables
used to assess oxidative status in erythrocytes and body weight, body
condition score, or serum concentrations of fructosamine, albumin,
total protein, triglycerides, or cholesterol. With regard to fructosamine
concentration, correlations were also not observed after repeating the
analysis by controlling for the potential confounding effect of albumin
and total protein (ie, partial correlation analysis test).
A weak positive correlation existed between the concentrations
of membrane carbonyls and membrane AOPP (r = 0.476; P = .01), but
not between the remaining variables used to assess oxidative status.
3.2 | Clamps in purpose-bred healthy cats
To determine if hyperglycemia and hyperlipidemia, which are hall-
marks of DM, are responsible for the oxidative stress observed in dia-
betic cats, purpose-bred healthy cats were used.23 The purpose-bred
healthy cats had a median age of 16 months (range: 15-18), median
body weight of 4.3 kg (range: 3.5-4.7), and a median body condition
score of 5 (range: 4-5). They were all neutered male, domestic short-
hair cats. In glucose-infused cats, the expected glucose range
(25-30 mmol/L) was reached within 3-5 hours after the start of infu-
sion and maintained for 10 consecutive days. Based on daily physical
examination and electrolyte monitoring, the cats were considered to
be in good health throughout the experiment. Urine dipstick
(Combur10-Test, Roche, Rotkreuz, Switzerland) testing showed
severe glycosuria (4+) starting on day 1 and continuing throughout
the 10-day period; ketonuria was not detected at any time point. The
target concentration for triglycerides was set at 3-7 mmol/L for most
of the infusion period in lipid-infused cats. For 2 days, the target con-
centration was difficult to achieve in 3 cats and the concentration of
triglycerides transiently reached 23-45 mmol/L. During that time, 2 of
the cats became lethargic, but this resolved rapidly after reduction of
the lipid infusion rate. In saline-infused cats and in cats that were not
treated, physical examination findings were normal. Food intake
F IGURE 4 Before-and-after plot of cytoplasmic thiols in
erythrocytes of cats with diabetes mellitus (DM) at the time of
diagnosis and 12-16 weeks later, and dot plot of healthy control cats.
Diabetic cats had significantly lower concentrations than controls at
both time points. The values at the time of diagnosis and
12-16 weeks later did not differ in diabetic cats
TABLE 2 Oxidative status of erythrocytes (medians and ranges) of purpose-bred healthy cats that received intravenous glucose, lipids, or
saline, or no treatment
Variable Glucose-infusion (n = 5) Lipid-infusion (n = 6) Saline-infusion (n = 5) No treatment (n = 5)
Membrane carbonyls (nmol/mg) 7.0 (5.5-8.3) 6.2 (3.3-8.3) 3.9 (2.9-7.8) 4.9 (2.4-6.2)
Membrane AOPP (nmol/mg) 37 (17-47) 16 (6-52) 16 (14-51) 33 (9-45)
Cytoplasmic TBAR (nmol/mg) 2.5 (2.0-2.7) 2.1 (1.2-2.8) 2.5 (1.9-2.8) 2.4 (1.9-2.8)
Membrane thiols (nmol/mg) 162 (54-478) 78 (17-175) 57 (31-361) 78 (31-169)
Cytoplasmic thiols (nmol/mg) 509 (427-525) 473 (416-598) 489 (433-501) 464 (423-566)
Abbreviations: AOPP, advanced oxidized protein products; TBAR, thiobarbituric acid reactive substances.
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appeared to be unaltered in all cats during the course of the study; at
the end of the experiment body weight of lipid-infused cats was
increased on average by 10% (P < .05) and did not change in the other
groups. None of the cats required any medication.23
3.2.1 | Variables of oxidation and antioxidant
defense
The 10-day period of hyperglycemia and hyperlipidemia did not lead
to differences in any of the variables used to evaluate oxidative status
of erythrocytes compared with values in cats that received saline or in
cats that were not treated. The findings of cats treated with saline did
not differ from those of cats that were not treated (Table 2).
4 | DISCUSSION
To date, there are limited data substantiating the presence of oxidative
stress in diabetic cats.18,19 In the present study, erythrocytes of newly
diagnosed diabetic cats had higher concentrations of membrane car-
bonyls and lower levels of cytoplasmic TBAR and thiols compared with
well-matched healthy controls. After 12-16 weeks of treatment, the con-
centration of carbonyls decreased but remained higher than in controls,
and the concentration of TBAR and thiols remained lower. The results of
the variables at the time of diagnosis and 12-16 weeks later did not dif-
fer between diabetic cats in remission and those that did not achieve
remission, but cats in remission had a transient decrease in AOPP at
6-8 weeks. Ten-day hyperglycemic and hyperlipidemic clamps did not
affect the oxidative status of erythrocytes of purpose-bred cats.
Hence, the increased concentrations of membrane carbonyls and
decreased concentrations of cytoplasmic thiols in the erythrocytes of
diabetic cats in the present study clearly suggests that oxidative stress
occurs in untreated diabetic cats at the time of diagnosis, similar to
findings in humans with type 1 and type 2 DM.7,10,11 It is difficult to
explain why differences were not evident in previous studies, particu-
larly when diabetic cats were considerably older and had higher body
weight.18,19 Aging and obesity in humans are associated with
increased oxidative stress of erythrocytes, and thus differences would
have been expected in older and heavier cats.29,30
The median concentration of membrane carbonyls in diabetic cats
at the time of diagnosis was approximately 6-fold higher than in con-
trols, but the variability of the results was also striking. In fact, the
concentration of membrane carbonyls was almost undetectable in
approximately 20% of cats with DM. The reason for the extreme vari-
ability is unclear. Cats with high concentrations of membrane car-
bonyls might have had DM long before it was diagnosed. Analysis of
the subset of diabetic cats with low concentrations of membrane car-
bonyls did not show any obvious similarities with regard to age, sex,
serum fructosamine concentration, body weight, or body condition
score. Additionally, 50% of these cats achieved remission during the
study period, which was comparable to the percentage of the entire
group of diabetic cats.
In cats with DM, the median concentration of cytoplasmic thiols
at the time of diagnosis was 35% lower than in the control group.
Therefore, the overall antioxidant reserve of thiols in the erythrocytes
of diabetic cats is reduced, although the partial overlap of thiol con-
centrations of the 2 groups suggested that it was not compromised in
all cases. Glutathione, which is the predominant antioxidant of the
thiols and found to be normal in diabetic cats,5,9 was not measured in
the present study. However, if there had been no abnormalities in glu-
tathione concentration, other thiol-based antioxidants should have
been decreased to explain their reduction in the present study. In fact,
the thiols contain various substances with sulfhydryl groups (ie, SH),
which are all targets for reactive oxygen and nitrogen species, thus
counteracting the effect of pro-oxidants.29 In contrast to erythrocyte
cytoplasm, the concentration of thiols in erythrocyte membranes did
not differ between the 2 groups. Impaired antioxidant defense has
been observed in erythrocyte membranes of humans with type
2 DM.31 It is possible that erythrocyte membranes in cats can com-
pensate for oxidation.
An unexpected finding was the decreased concentration of cyto-
plasmic TBAR of erythrocytes in diabetic cats at the time of diagnosis
compared with controls, but there was a large overlap between the
2 groups. Peroxidation of polyunsaturated fatty acids leading to gen-
eration of ketones and aldehydes, including malondialdehyde, has
been frequently described in humans with type 1 and type 2 DM.6,9 In
contrast, studies of diabetic cats showed that the concentrations of
TBAR in erythrocytes and malondialdehyde in whole blood were simi-
lar to those in controls.18,19 Known differences between erythrocytes
of cats and humans do not help explain this finding; feline hemoglobin
contains 8 free reactive sulfhydryl groups, whereas human hemoglo-
bin has only 2.32,33 This would suggest less resistance to oxidative
stress in diabetic cats. Hence, other antioxidant defenses might have
protected cat erythrocytes preventing an increase of TBAR. Nonethe-
less, similar concentrations of TBAR were expected in healthy and dia-
betic cats rather than a decreased concentration in the latter.
Unfortunately, TBAR concentration was not measured in erythrocyte
membranes to verify if it was also decreased. The decrease in TBAR
levels in diabetic cats cannot be explained. It cannot be excluded that
long-term storage partly affected the results, although the potential
bias was evenly distributed between diabetic and control cats.
There was no difference in the concentration of membrane AOPP
of erythrocytes in diabetic and control cats initially. Although differ-
ences were not identified, there was a positive correlation between
AOPP and carbonyls in erythrocyte membranes, which appears intui-
tive because both are by-products of protein oxidation.2,3 There were
no other correlations between variables used to assess oxidative sta-
tus in erythrocytes or between those variables and clinical or labora-
tory findings, although weak significant correlations may have been
missed because of the sample size. A negative correlation between
serum fructosamine concentration and total antioxidant potential of
plasma was reported in humans with type 2 DM.34 Associations
between fructosamine or glycated hemoglobin and carbonyls, AOPP,
TBAR, and thiols in the erythrocytes of diabetic humans have not
been explored.
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The concentration of carbonyls in erythrocyte membranes was
decreased by 13% in diabetic cats 12-16 weeks after the time of diag-
nosis, indicating that treatment led to a reduction in oxidation. How-
ever, decreases in carbonyls were generally small and did not occur in
all cats, and the concentration of carbonyls remained higher in dia-
betic cats compared with controls. In addition, cytoplasmic thiols did
not increase and remained lower in diabetic cats than in controls.
Overall, our results suggest that oxidative stress is persistent in dia-
betic cats and antioxidant defenses remain inadequate despite treat-
ment. It is possible that a longer period of treatment with insulin
would have improved the oxidative status. However, in humans with
type 2 DM, euglycemic hyperinsulinemic clamps result in normaliza-
tion of erythrocyte oxidative defenses after 120 minutes, based on
assessment of the glutathione redox state.13 Thus, it is possible that
improvement in the oxidative status of erythrocytes in diabetic cats
would have occurred if insulin treatment had led to normoglycemia.
Surprisingly, at 12-16 weeks, variables used to assess oxidative stress
did not differ between diabetic cats in remission and those that had
not achieve remission, which led us to question the possibility of
improvement in oxidative stress via normoglycemia alone. However, it
is possible that an imbalance in oxidative status precedes the develop-
ment of DM and is only partly related to insulin treatment and hyper-
glycemia. This notion is supported by the observation that
erythrocytes from nondiabetic parents and siblings of humans with
type 1 DM have increased oxidative stress.35
It was not possible to predict diabetic remission based on the var-
iables used to assess oxidative status, and differences in those vari-
ables between cats in remission and not in remission were not seen at
12-16 weeks. The only difference was noticed at 6-8 weeks when the
median concentration of membrane AOPP was approximately 40%
lower in cats that achieved remission. However, the reduction was
transient and there was a large overlap between the 2 groups, render-
ing this variable impractical for clinical use. The finding that oxidative
stress is persistent in cats in diabetic remission might explain why
there are low numbers of β-cells in the pancreatic islets of cats in
remission.36 Indeed, pancreatic β-cells of humans and rats are sensi-
tive to oxidative stress because of their low antioxidant defenses.37
Should this be applicable to cats, persistent oxidative stress during
diabetic remission would likely be a contributing factor in β-cell
failure.
To determine whether the diabetic milieu of plasma, which is
characterized by hyperglycemia and hyperlipidemia, causes an
increase in oxidative stress as observed in the erythrocytes of
untreated diabetic cats, healthy purpose-bred cats were infused with
glucose and lipids for 10 days to reach concentrations typically
observed in DM.23 The concentration of the variables used to assess
oxidation and oxidative defenses were not affected by hyperglycemia
or hyperlipidemia in healthy cats. Hence, increased blood glucose or
lipid concentrations per se do not induce oxidative stress in the eryth-
rocytes of healthy purpose-bred cats. It is possible that oxidative
stress requires a longer period of hyperglycemia and hyperlipidemia,
or that other factors in addition to hyperglycemia and hyperlipidemia
are involved. To our knowledge, similar in vivo studies have not been
conducted in other species to test these theories. In humans with type
2 DM, chronic sustained hyperglycemia was less of a specific trigger
for oxidative stress than fluctuations in glucose concentration during
postprandial periods and, more generally, during glucose swings.38
Whether this represents an alternative explanation to our findings in
purpose-bred cats requires further investigation. Of note, despite
body weight increased after hyperlipidemic clamps in cats, concentra-
tions of variables used to assess oxidative status were not affected. In
humans with morbid obesity, increased carbonyls and decreased thiols
are observed.30 It is possible that the body weight increase was rela-
tively low in cats (approximately 10%) to cause oxidative stress.
The present study had some limitations. Glutathione, glutathione
peroxidase, and superoxide dismutase, which are important variables
for determining oxidative stress,5 were not measured in the erythro-
cytes of the cats. With particular reference to lipid peroxidation, mea-
suring other more specific by-products including F2-isoprostanes,
malondialdehyde, hydroperoxyoctadecadienoic acids, and oxysterols
would have possibly addressed the reasons for decreased cytoplasmic
TBAR in erythrocytes of diabetic cats.39 Moreover, plasma was not
available for the measurement of other variables such as total reactive
oxygen and nitrogen species and the total antioxidant potential.34
Worth mentioning, most tests to characterize oxidative stress have
not been used and validated in small animals, especially in cats. In
addition, the number of cases included in the study with diabetic cats
and in the experiment with purpose-bred cats was limited, possibly
causing type II statistical errors; therefore, any negative finding should
be regarded cautiously. Moreover, 2 cats with ketoacidosis were
included. However, because they were few and in relatively good con-
ditions at diagnosis, it is unlikely that they affected the final assump-
tions. Finally, erythrocytes collected from the purpose-bred cats
before the start of the infusions were not available for comparison of
the oxidative status among groups.
In conclusion, DM is associated with an increase in the concentra-
tion of oxidized protein and a decrease in antioxidant defense in cat
erythrocytes at the time of diagnosis, and these changes largely persist
during treatment and remission, although a mild decrease in the level of
protein oxidation was seen. Evaluation of the oxidative status of erythro-
cytes at the time of diagnosis does not aid in predicting diabetic remis-
sion. Short-term hyperglycemia or hyperlipidemia alone does not appear
to cause oxidative stress in feline erythrocytes. The reasons for
decreased concentrations of TBAR in diabetic cats remain unclear.
Future studies should verify if treatment of oxidative stress improves gly-
cemic control and increases the chance of remission in diabetic cats.
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